Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | March 01, 2024 01:34pm

Gainers

  • Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 58.8% to $3.24 during Friday's regular session. The market value of their outstanding shares is at $5.3 million.
  • BioVie (NASDAQ:BIVI) stock increased by 48.38% to $1.84. The company's market cap stands at $73.3 million.
  • Cardiff Oncology (NASDAQ:CRDF) shares moved upwards by 30.72% to $2.31. The market value of their outstanding shares is at $103.0 million. As per the news, the Q4 earnings report came out yesterday.
  • Myomo (AMEX:MYO) stock increased by 29.73% to $3.97. The market value of their outstanding shares is at $110.6 million.
  • Altamira Therapeutics (NASDAQ:CYTO) stock rose 24.46% to $2.34. The market value of their outstanding shares is at $3.6 million.
  • MSP Recovery (NASDAQ:LIFW) shares moved upwards by 24.11% to $1.05. The company's market cap stands at $15.6 million.

Losers

  • Scilex Holding (NASDAQ:SCLX) shares declined by 36.4% to $1.45 during Friday's regular session. The company's market cap stands at $228.1 million.
  • Precision BioSciences (NASDAQ:DTIL) stock fell 34.0% to $12.21. The market value of their outstanding shares is at $49.6 million.
  • DermTech (NASDAQ:DMTK) shares decreased by 32.12% to $0.87. The company's market cap stands at $29.7 million. As per the news, the Q4 earnings report came out yesterday.
  • Vivani Medical (NASDAQ:VANI) stock decreased by 25.83% to $3.13. The market value of their outstanding shares is at $159.7 million.
  • Gritstone Bio (NASDAQ:GRTS) shares declined by 22.25% to $2.18. The market value of their outstanding shares is at $207.5 million.
  • Humacyte (NASDAQ:HUMA) shares fell 20.81% to $3.44. The market value of their outstanding shares is at $356.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADIL BIVI CRDF CYTO DMTK DTIL GRTS HUMA LIFW MYO SCLX VANI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist